NAPLEX Practice Exam 2026 – Comprehensive Test Preparation

An Assessment of Risk must be reviewed regularly in order to ensure the safety and efficacy of a drug. While an Assessment of Risk for higher risk drugs may need to be reviewed every 6 months or even monthly, for drugs with lower risk, a review at least every 12 months is sufficient. This is because lower risk drugs typically have a lower likelihood of causing adverse effects and therefore require less frequent monitoring and assessment. Options A, C, and D are incorrect because they suggest review frequencies that are either too frequent or too infrequent for drugs with lower risk.